Antibodies specific for sclerostin and methods for increasing bone mineralization

Details for Australian Patent Application No. 2004262640 (hide)

Owner UCB Manufacturing, Inc.

Inventors Shi, Jiye; Winkler, David G.; Latham, John

Agent Davies Collison Cave

Pub. Number AU-B-2004262640

PCT Pub. Number WO2005/014650

Priority 60/478,977 16.06.03 US

Filing date 15 June 2004

Wipo publication date 17 February 2005

Acceptance publication date 23 December 2010

International Classifications

A61P 19/10 (2006.01) Drugs for skeletal disorders

C07K 14/51 (2006.01) Peptides having more than 20 amino acids

Event Publications

2 February 2006 PCT application entered the National Phase

  PCT publication WO2005/014650 Priority application(s): WO2005/014650

18 November 2010 Assignment before Grant

  Celltech R & D, Inc. The application has been assigned to UCB Manufacturing, Inc.

23 December 2010 Application Accepted

  Published as AU-B-2004262640

21 April 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004262642-Epoxy-capped polythioethers

2004262637-Method for producing a polypeptide